Team-NB members adopted during the General Assembly meeting, at the unanimity of the IVD NBs presents, a guidance on the interpretation used by notified bodies to identify changes affecting the performance, suitability, or intended use of a companion diagnostic device that necessitate consultation with medicinal product authorities.
